Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

Fig. 2

Aerodynamic particle size distribution from BGF MDIs. Comparison of budesonide, glycopyrrolate, and formoterol fumarate aerodynamic particle size distribution from non-radiolabeled BGF MDIs and radiolabeled BGF MDIs used in this study. The effective cut-off particle size for each stage is shown for an inhalation flow rate of 30 L/min. BD budesonide, BGF budesonide/glycopyrrolate/formoterol fumarate, FF formoterol fumarate, GP glycopyrrolate, MOC micro-orifice collector, MDI metered dose inhaler, NGI Next Generation Impactor

Back to article page